At a glance
ClinicalIndex Comparison RecordN/ACompleted· 1,320 enrolled
Drug / intervention
olfactory devicedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Validation of a Rapid Quantitative Test for Loss of Smell in COVID-19 Subjects
In Brief
An observational study evaluating olfactory device for COVID-19. Completed, enrolled 1,320 participants across 1 site.
Detailed Summary
The purpose of this study is to evaluate the performance of a non-invasive olfactory device as a rapid indicator of COVID-19 in positive subjects.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCOVID-19
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
202120222023202420252026
Enrollment StartJun 2020
First PostedJun 2020
Primary CompletionOct 2020
Study CompletionNov 2020
TodayJul 2026
First PostedJun 16, 2020
Enrollment StartJun 15, 2020
Primary CompletionOct 15, 2020
Study CompletionNov 18, 2020
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 6.0 years ago
Interventions
olfactory devicedevice
A quantitative non-biased olfactory device intended for the rapid identification of SARS-CoV-2 infected subjects (as identified by PCR).